Fritextsökning
Innehållstyper
-
9 steps to perfect partnering
Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Studie: Så länge klarar sig corona på olika ytor
Klarar sig i timmar i luftburna aerosoler och i flera dagar på olika ytor.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Här lyfts morgondagens diagnostik
Morgondagens innovativa labbtekniker inom olika typer av diagnostik måste uppmärksammas. Det var fröet till det internationella seminariet Lab & Diagnostics of ...
-
Stor kartläggning av svensk läkemedelsutveckling - "Väldigt imponerande bidrag"
Trots tuffa tider planerar två av tre life science-bolag att nyrekrytera – och antalet läkemedelsprojekt fortsätter att öka. Det visar branschorganisationen Swe...
-
KI-professor får pris
Prisas för forskning på kopplingen mellan arv och miljö i samband med reumatoid artrit.
-
LabDays: ”Det är en ganska mörk bild jag pekar ut nu”
Utmaningar inom global hälsa, analys av torkat blod, gensekvensering, manlig infertilitet och detektion av droger i saliv var några av de ämnen som avhandlades ...
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Läkemedel för lupussjuka på väg att ta slut
Trots bristande evidens förskrivs läkemedel med hydroxiklorokin till covid-19-patienter runt om i världen. Nu rapporterar The Guardian att substansen, som är li...
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Studie: Barns immunförsvar anpassade sig till hepatit C-viruset under graviditeten
Forskare vid Karolinska institutet har i en ny studie om nyfödda visat att både smittade och osmittade barn anpassade sig till viruset. Resultaten kan öppna upp...
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Klinisk studie av läkemedel mot apkoppor inleds i USA
Forskare i USA vill ta reda på hur väl det antivirala läkemedlet tekovirimat hjälper mot apkoppor. Nu inleds en fas III-studie.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
BREAKING